GoodRx Holdings (GDRX) Stock Forecast & Price Target

Compare

1,310 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GDRX Analyst Ratings

Hold

4 Buy

4 Hold

2 Sell

Based on 10 analysts giving stock ratings to

GoodRx

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GDRX Stock 12 Month Forecast

Average Price Target

$4.46

▲(66.42% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for GoodRx Holdings in the last 3 months. The average price target is $4.46 with a high forecast of $7.00 and a low forecast of $2.60. The average price target represents a 66.42% change from the last price of $2.68.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","8":"$8","2.75":"$2.75","4.5":"$4.5","6.25":"$6.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$7.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.75,4.5,6.25,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,3.04,3.37,3.7,4.03,4.36,4.6899999999999995,5.02,5.35,5.68,6.01,6.34,6.67,{"y":7,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.8446153846153845,2.979230769230769,3.1138461538461537,3.2484615384615383,3.383076923076923,3.5176923076923075,3.6523076923076925,3.7869230769230766,3.9215384615384616,4.056153846153846,4.190769230769231,4.325384615384616,{"y":4.46,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.7015384615384614,2.693076923076923,2.6846153846153844,2.6761538461538463,2.667692307692308,2.6592307692307693,2.6507692307692308,2.6423076923076922,2.6338461538461537,2.6253846153846156,2.616923076923077,2.6084615384615386,{"y":2.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.64,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.53,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.3,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 44, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$7.00

Average Price Target$4.46

Lowest Price Target$2.60

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Daniel Grosslight

Citi

$5→$4.5

Buy

67.91%

Upside

Reiterated

01/09/26

GoodRx price target lowered to $4.50 from $5 at CitiGoodRx price target lowered to $4.50 from $5 at Citi

Allen Lutz

Bank of America Securities

$3→$2.6

Sell

-2.99%

Downside

Reiterated

01/05/26

Bank of America Securities Remains a Sell on GoodRx Holdings (GDRX)

Craig Hettenbach

Morgan Stanley

$5→$4

Hold

49.25%

Upside

Reiterated

12/18/25

GoodRx price target lowered to $4 from $5 at Morgan StanleyGoodRx price target lowered to $4 from $5 at Morgan Stanley

Glen Santangelo

Barclays

Sell

11.94%

Upside

Initiated

12/08/25

GoodRx initiated with an Underweight at BarclaysGoodRx initiated with an Underweight at Barclays

Lisa Gill

J.P. Morgan

$6→$5

Buy

86.57%

Upside

Reiterated

11/11/25

GoodRx price target lowered to $5 from $6 at JPMorganGoodRx price target lowered to $5 from $6 at JPMorgan

Charles Rhyee

TD Cowen

$7→$6

Buy

123.88%

Upside

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and GoodRx Holdings (NASDAQ: GDRX)

Kevin Caliendo

UBS

$4.25→$4

Hold

49.25%

Upside

Reiterated

11/06/25

UBS Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

Steven Valiquette

Mizuho Securities

$5→$4

Hold

49.25%

Upside

Reiterated

11/06/25

GoodRx price target lowered to $4 from $5 at MizuhoGoodRx price target lowered to $4 from $5 at Mizuho

Jailendra Singh

Truist Financial

Hold

―

Reiterated

11/06/25

GoodRx Holdings (GDRX) Receives a Hold from Truist Financial

Stan Berenshteyn

Wells Fargo

Buy

161.19%

Upside

Reiterated

11/05/25

Buy Rating for GoodRx Holdings: Strategic Initiatives and Growth Prospects Amid Challenges

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/02/25

We reiterate our Outperform rating on GDRX on this potential significant positive update.

George Hill

Deutsche Bank

$8→$6

Hold

123.88%

Upside

Reiterated

08/11/25

GoodRx price target lowered to $6 from $8 at Deutsche BankGoodRx price target lowered to $6 from $8 at Deutsche Bank

Eric Sheridan

Goldman Sachs

$5→$3.75

Hold

39.93%

Upside

Reiterated

08/11/25

Goldman Sachs Sticks to Their Hold Rating for GoodRx Holdings (GDRX)

John Ransom

Raymond James

$9→$5

Buy

86.57%

Upside

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), GoodRx Holdings (NASDAQ: GDRX) and Enhabit, Inc (NYSE: EHAB)

Sean Dodge

BMO Capital

Buy

123.88%

Upside

Reiterated

02/27/25

GoodRx Holdings (GDRX) Gets a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Daniel Grosslight

Citi

$5→$4.5

Buy

67.91%

Upside

Reiterated

01/09/26

GoodRx price target lowered to $4.50 from $5 at CitiGoodRx price target lowered to $4.50 from $5 at Citi

Allen Lutz

Bank of America Securities

$3→$2.6

Sell

-2.99%

Downside

Reiterated

01/05/26

Bank of America Securities Remains a Sell on GoodRx Holdings (GDRX)

Craig Hettenbach

Morgan Stanley

$5→$4

Hold

49.25%

Upside

Reiterated

12/18/25

GoodRx price target lowered to $4 from $5 at Morgan StanleyGoodRx price target lowered to $4 from $5 at Morgan Stanley

Glen Santangelo

Barclays

Sell

11.94%

Upside

Initiated

12/08/25

GoodRx initiated with an Underweight at BarclaysGoodRx initiated with an Underweight at Barclays

Lisa Gill

J.P. Morgan

$6→$5

Buy

86.57%

Upside

Reiterated

11/11/25

GoodRx price target lowered to $5 from $6 at JPMorganGoodRx price target lowered to $5 from $6 at JPMorgan

Charles Rhyee

TD Cowen

$7→$6

Buy

123.88%

Upside

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and GoodRx Holdings (NASDAQ: GDRX)

Kevin Caliendo

UBS

$4.25→$4

Hold

49.25%

Upside

Reiterated

11/06/25

UBS Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

Steven Valiquette

Mizuho Securities

$5→$4

Hold

49.25%

Upside

Reiterated

11/06/25

GoodRx price target lowered to $4 from $5 at MizuhoGoodRx price target lowered to $4 from $5 at Mizuho

Jailendra Singh

Truist Financial

Hold

―

Reiterated

11/06/25

GoodRx Holdings (GDRX) Receives a Hold from Truist Financial

Stan Berenshteyn

Wells Fargo

Buy

161.19%

Upside

Reiterated

11/05/25

Buy Rating for GoodRx Holdings: Strategic Initiatives and Growth Prospects Amid Challenges

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/02/25

We reiterate our Outperform rating on GDRX on this potential significant positive update.

George Hill

Deutsche Bank

$8→$6

Hold

123.88%

Upside

Reiterated

08/11/25

GoodRx price target lowered to $6 from $8 at Deutsche BankGoodRx price target lowered to $6 from $8 at Deutsche Bank

Eric Sheridan

Goldman Sachs

$5→$3.75

Hold

39.93%

Upside

Reiterated

08/11/25

Goldman Sachs Sticks to Their Hold Rating for GoodRx Holdings (GDRX)

John Ransom

Raymond James

$9→$5

Buy

86.57%

Upside

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), GoodRx Holdings (NASDAQ: GDRX) and Enhabit, Inc (NYSE: EHAB)

Sean Dodge

BMO Capital

Buy

123.88%

Upside

Reiterated

02/27/25

GoodRx Holdings (GDRX) Gets a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GoodRx Holdings

3 Months

xxx

Success Rate

14/20 ratings generated profit

Average Return

+8.91%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +8.91% per trade.

1 Year

Allen LutzBank of America Securities

Success Rate

19/20 ratings generated profit

Average Return

+29.97%

reiterated a sell rating 14 days ago

Copying Allen Lutz's trades and holding each position for 1 Year would result in 95.00% of your transactions generating a profit, with an average return of +29.97% per trade.

2 Years

xxx

Success Rate

19/20 ratings generated profit

Average Return

+36.20%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.00% of your transactions generating a profit, with an average return of +36.20% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GDRX Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GDRX has received 6 Buy Ratings, 22 Hold Ratings, and 4 Sell Ratings. GDRX average Analyst price target in the past 3 months is 4.46.

Each month's total comprises the sum of three months' worth of ratings.

GDRX Financial Forecast

GDRX Earnings Forecast

Next quarter’s earnings estimate for GDRX is $0.09 with a range of $0.08 to $0.11. The previous quarter’s EPS was $0.08. GDRX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GDRX has Performed in-line its overall industry.

GDRX Sales Forecast

Next quarter’s sales forecast for GDRX is $192.83M with a range of $191.00M to $194.70M. The previous quarter’s sales results were $196.03M. GDRX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GDRX has Performed in-line its overall industry.

GDRX Stock Forecast FAQ

What is GDRX’s average 12-month price target, according to analysts?

Based on analyst ratings, GoodRx Holdings’s 12-month average price target is 4.46.

What is GDRX’s upside potential, based on the analysts’ average price target?

GoodRx Holdings has 66.42% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GDRX a Buy, Sell or Hold?

GoodRx Holdings has a consensus rating of Hold which is based on 4 buy ratings, 4 hold ratings and 2 sell ratings.

What is GoodRx Holdings’s price target?

The average price target for GoodRx Holdings is 4.46. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $2.60. The average price target represents 66.42% Increase from the current price of $2.68.

What do analysts say about GoodRx Holdings?

GoodRx Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of GDRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

GoodRx Holdings (GDRX) Stock Forecast & Price Target

GDRX Analyst Ratings

GDRX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GoodRx Holdings

GDRX Analyst Recommendation Trends

GDRX Financial Forecast

GDRX Earnings Forecast

GDRX Sales Forecast

GDRX Stock Forecast FAQ

Detailed List of Analyst Forecasts